Jeff Yass’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
Other funds holding NAMS
DFO
Jeff Yass's NAMS Position: Q3 2026 in Review
Jeff Yass reduced its NewAmsterdam Pharma (NAMS) stake by 62% in Q3 2026, selling an estimated $12.9M and leaving 286,860 shares worth $6.98M. The position accounts for ﹤0.01% of the portfolio, ranked #3890.
Jeff Yass first reported a position in NAMS in Q4 2024 and has held it in 8 quarters since. The position peaked at $25.6M in Q2 2026. 183 funds tracked by Wall St. Rank hold NAMS as of Q3 2026.
- Jeff Yass held 286,860 shares of NewAmsterdam Pharma worth $6.98M as of Q3 2026.
- Jeff Yass sold 467,467 NewAmsterdam Pharma shares in Q3 2026, an estimated $12.9M.
- NewAmsterdam Pharma made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #3890 holding.
- Jeff Yass first reported a position in NewAmsterdam Pharma in Q4 2024 and has held it in 8 quarters since.
- Jeff Yass's NewAmsterdam Pharma position peaked at $25.6M in Q2 2026.
- 183 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.